Ultra-Rare Cancers Partnership Launches With Two Pilot Indications, Seeks Industry Help

 
• By Sue Sutter
  
End to end
The ULTRA program will pursue end-to-end development of therapies for ultra-rare cancers. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from United States